ulcerative colitis

2 Biotech Companies With Strong Product Launches To Monitor

2 Biotech Companies With Strong Product Launches To Monitor

Seeking Alpha

Coronado Biosciences: 2013 - Year Of The Worm

Coronado Biosciences: 2013 - Year Of The Worm

Seeking Alpha

Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis

Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis

PharmaLive

Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis

Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis

Yahoo

Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product

Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product

Yahoo

Santarus Stock Pops To 8-Year High On Drug Approval

Santarus Stock Pops To 8-Year High On Drug Approval

Investors.com

Synergy Pharmaceuticals: Monday's Pipeline News Strengthens Company At Its Core

Synergy Pharmaceuticals: Monday's Pipeline News Strengthens Company At Its Core

Seeking Alpha

Abbott announces results from analysis of extension of Humira studies

Abbott announces results from analysis of extension of Humira studies

The Fly on the Wall

New Indication for Abbott's Humira

New Indication for Abbott's Humira

Yahoo/Zacks

Abbott's Humira (adalimumab) Receives U.S. FDA Approval for the Treatment of Adult Patients with Moderate to Severe Ulcerative Colitis

Abbott's Humira (adalimumab) Receives U.S. FDA Approval for the Treatment of Adult Patients with Moderate to Severe Ulcerative Colitis

Yahoo/PR Newswire